AZ, BMS, Lilly, Pfizer make investor's cut

Investor Osman Gulseven finds that of hundreds of healthcare companies listed on the New York Stock Exchange, only four fit his investment objective of  high profitability, substantial dividends and a maximum P/E ratio of 20. Each is a  large-cap drugmaker: AstraZeneca , Bristol-Myers Squibb, Eli Lilly & Co, and Pfizer. Article